Tech Company Financing Transactions
DioGenix Funding Round
DioGenix closed a $1.5 million Series B funding round on 12/19/2012. Backers included Nerveda.
Transaction Overview
Company Name
Announced On
12/19/2012
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Series B
Investors
Proceeds Purpose
Molecular diagnostics company DioGenix Inc . said it raised $1.5 million in Series B financing provided by existing investors including life sciences fund Nerveda LLC, which it plans to use to take its multiple sclerosis diagnostic test through clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Bethesda Metro Center 700
Bethesda, MD 20814
USA
Bethesda, MD 20814
USA
Phone
Website
Email Address
Overview
DioGenix develops and commercializes non-invasive diagnostic and prognostic treatment response monitoring tests.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Tiffany
Chief Financial Officer
Richard Vincent
Chief Scientific Officer
Eric Eastman
Browse more venture capital transactions:
Prev: 12/19/2012: Proterro venture capital transaction
Next: 12/19/2012: Noom venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs